Skip to main content

The Burden of Delayed Parathyroidectomy in Asymptomatic Patients With Primary Hyperparathyroidism

In brief

Delayed parathyroid surgery linked to 30% higher risks of bone loss and kidney stones

In this matched retrospective study of adults with asymptomatic primary hyperparathyroidism, surgery more than two years after diagnosis was associated with 30% higher risks of osteoporosis without fracture and kidney stones than earlier surgery. Higher cumulative risks of several cardiovascular outcomes were also observed, but the study cannot show that delay caused these complications; prospective studies are needed to test whether earlier surgery prevents them.

Journal
The Journal of surgical research (Q1)
Published
18 November 2026
Study design
Prospective / inception cohort
Evidence level
Level 2, Moderate (CEBM 2b)
Authors
Raj Roy, Abdullah Ahmed, Rongzhi Wang, Juan Contreras, Rachael Caretti, Niranjna Swaminathan, et al.
PMID
43051001
DOI
10.1016/j.jss.2026.10.032

Why clinicians should know about it

  • Picked for Breast and Endocrine Surgery (paper of the day, 20 November 2026): Primary hyperparathyroidism surgery timing and end-organ outcomes

Abstract

INTRODUCTION: Patients with primary hyperparathyroidism (PHPT) can experience delays in receiving definitive parathyroidectomy (PTx). However, the association between such delays and end-organ complications remains unexplored. This study aims to evaluate the association between delayed definitive treatment and adverse skeletal, renal, and cardiovascular outcomes in patients with asymptomatic PHPT. METHODS: We conducted a retrospective cohort study using a multi-institutional electronic health record network to create a cohort of adults diagnosed with PHPT and restricted to the asymptomatic population by excluding patients with osteoporosis, nephrolithiasis, and cardiovascular outcomes of interest. Patients were stratified into two groups based on the timing of surgery relative to diagnosis of PHPT: early (<2 y) or delayed (>2 y). Propensity score matching was done to balance demographics, Charlson comorbidities, laboratory values, and medication use before the index event. Primary outcomes were osteoporosis with and without fracture, nephrolithiasis, and cardiovascular events, assessed from the index date of diagnosis and surgery. Cumulative risks and Cox regression analysis were performed to assess the measure of associations. RESULTS: Among 178,312 adults diagnosed with PHPT, 69,270 (38.8%) underwent PTx. Of 26,946 asymptomatic patients meeting inclusion criteria, 24,710 (91.7%) received early surgery, and 2476 (8.3%) underwent delayed surgery. After propensity score matching, 2260 patients were included in each cohort (mean age 59 y; 81% female; 65% White). From the time of diagnosis, delayed PTx was associated with significantly higher cumulative risks of osteoporosis without fracture, nephrolithiasis, and multiple cardiovascular outcomes. Time-to-event analyses demonstrated worse event-free survival in the delayed cohort for osteoporosis without fracture (Hazard ratio 1.3, P < 0.01), and nephrolithiasis (Hazard ratio 1.3, P < 0.01). When anchored to the time of surgery, delayed PTx remained associated with higher cumulative and time-dependent risks of osteoporosis with and without fracture. CONCLUSIONS: Delayed PTx was associated with a greater burden of osteoporosis and nephrolithiasis than early surgery. The association with osteoporosis persisted when outcomes were measured from the time of surgery. Prospective studies are needed to determine whether earlier surgery changes these outcomes.

Abstract as published, via PubMed.

View on PubMedFull text at the publisherOpen in the app

For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.